Methods, application insights, and new column updates
English | Global
Zodiac C8(1)
A specialized C8 stationary phase tailored for distinct alternative selectivity and the efficient resolution of moderately polar analytes.
Internal Diameter (mm)
Length (mm)
Particle Size (µm)
| Product Name | Internal Diameter (mm) | Length (mm) | Particle Size (µm) | Pore Size (Å) | Quantity | Add to Cart | Wishlist |
|---|---|---|---|---|---|---|---|
| Zodiac C8(1) : 100mm x 2.0mm,5um ZLS.C8(1).20.100.0519 | 2.0 | 100 | 5 | 190 |
|
||
| Zodiac C8(1) : 100mm x 3.0mm,5um ZLS.C8(1).30.100.0519 | 3.0 | 100 | 5 | 190 |
|
||
| Zodiac C8(1) : 100mm x 4.0mm,3um ZLS.C8(1).40.100.0319 | 4.0 | 100 | 3 | 190 |
|
||
| Zodiac C8(1) : 100mm x 4.0mm,5um ZLS.C8(1).40.100.0519 | 4.0 | 100 | 5 | 190 |
|
||
| Zodiac C8(1) : 100mm x 4.6mm,3um ZLS.C8(1).46.100.0319 | 4.6 | 100 | 3 | 190 |
|
No products found in this phase.
Distinct Alternative Selectivity with Robust Performance for Moderately Polar Analytes.
A tailored C8 stationary phase developed to offer distinct alternative selectivity. It delivers rapid, highly efficient separations specifically targeted for moderately polar analytes.
| USP Listing | L7 |
|---|---|
| Phase Type | Reverse Phase (RP) |
| Phase Ligand | C8(1) |
| Pore Size (Å) | 190 |
| Surface Area (m²/g) | 280 |
| Pore Volume (mL/g) | 1.1 |
| pH Range | 2-8 |
| Particle Size (µm) | 3,3.5,5,10 |
| Particle Technology | Fully Porous |
| Carbon Load (%) | 11% |
| End Capping | Yes |
| Max Temperature (°C) | 80 |
- Assay Of L-Arginine Using USP_32 Method
- Bortezomib- IP method on Zodiac C8(1)
- Cephalosporin Antibiotics Drugs
- Fatty Acids
- Glycine & It’s Related Compounds Of Glycine using API EP Method
- Omeprazole Chloro compound Analysis on Zodiac C8(1)
- Omeprazole USP Method on Zodiac C8(1)
- Paracetamol RS on Zodiac C8(1)
- Peptides
- Related Substances Of Furosemide (Frusemide) By HPLC
- Bedaquiline Fumarate Related Substances Analysis using Zodiac C8(1) Column
- Fluconazole Analysis using Zodiac C18 Column
ZODIAC Catalogue 2026Download PDF
